Skip to main content

Tango Therapeutics, Inc 10-Q for FY2024 Q2

Tango Therapeutics, Inc. (TNGX)

10-Q 2024-08-07 For: 2024-06-30
View Original
Added on April 08, 2026

About this 10-Q

Tango Therapeutics, Inc filed this 10-Q on August 7, 2024, covering the quarter ended June 30, 2024 (FY2024 Q2).

Headline figures

Quarter ended June 30, 2024, as reported in this filing, compared with the same period a year earlier where the filing states it.

Revenue
$19.88M
up 36.1% from $14.6M a year earlier
Net loss
$25.55M
compared with a net loss of $20.71M a year earlier
Diluted EPS
-$0.24
compared with -$0.23 a year earlier